JP2024537826A5 - - Google Patents

Info

Publication number
JP2024537826A5
JP2024537826A5 JP2024519821A JP2024519821A JP2024537826A5 JP 2024537826 A5 JP2024537826 A5 JP 2024537826A5 JP 2024519821 A JP2024519821 A JP 2024519821A JP 2024519821 A JP2024519821 A JP 2024519821A JP 2024537826 A5 JP2024537826 A5 JP 2024537826A5
Authority
JP
Japan
Prior art keywords
antigen
chain variable
variable region
heavy chain
binding polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519821A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537826A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077201 external-priority patent/WO2023056313A1/en
Publication of JP2024537826A publication Critical patent/JP2024537826A/ja
Publication of JP2024537826A5 publication Critical patent/JP2024537826A5/ja
Pending legal-status Critical Current

Links

JP2024519821A 2021-09-29 2022-09-28 抗原結合ポリペプチド、抗原結合ポリペプチド複合体、及びそれらを使用する方法 Pending JP2024537826A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US202163249833P 2021-09-29 2021-09-29
US202163249919P 2021-09-29 2021-09-29
US202163249722P 2021-09-29 2021-09-29
US202163249794P 2021-09-29 2021-09-29
US63/249,919 2021-09-29
US63/249,794 2021-09-29
US63/249,722 2021-09-29
US63/249,833 2021-09-29
US202163291305P 2021-12-17 2021-12-17
US63/291,305 2021-12-17
US202163292382P 2021-12-21 2021-12-21
US63/292,382 2021-12-21
PCT/US2022/077201 WO2023056313A1 (en) 2021-09-29 2022-09-28 Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024537826A JP2024537826A (ja) 2024-10-16
JP2024537826A5 true JP2024537826A5 (enExample) 2026-01-05

Family

ID=85783604

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2024519649A Pending JP2024537804A (ja) 2021-09-29 2022-09-28 抗原結合ポリペプチド、抗原結合ポリペプチド複合体、及びそれを使用する方法
JP2024519823A Pending JP2024537828A (ja) 2021-09-29 2022-09-28 抗原結合ポリペプチド、抗原結合ポリペプチド複合体、及びそれを使用する方法
JP2024519821A Pending JP2024537826A (ja) 2021-09-29 2022-09-28 抗原結合ポリペプチド、抗原結合ポリペプチド複合体、及びそれらを使用する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2024519649A Pending JP2024537804A (ja) 2021-09-29 2022-09-28 抗原結合ポリペプチド、抗原結合ポリペプチド複合体、及びそれを使用する方法
JP2024519823A Pending JP2024537828A (ja) 2021-09-29 2022-09-28 抗原結合ポリペプチド、抗原結合ポリペプチド複合体、及びそれを使用する方法

Country Status (11)

Country Link
US (3) US20230227553A1 (enExample)
EP (3) EP4408469A4 (enExample)
JP (3) JP2024537804A (enExample)
KR (3) KR20240099225A (enExample)
AU (3) AU2022354068A1 (enExample)
CA (3) CA3232364A1 (enExample)
CL (3) CL2024000907A1 (enExample)
IL (3) IL311765A (enExample)
MX (2) MX2024003808A (enExample)
TW (3) TW202330594A (enExample)
WO (3) WO2023056313A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
CN118251411A (zh) * 2021-09-29 2024-06-25 摩德斯医疗股份有限公司 抗原结合多肽、抗原结合多肽复合物及其使用方法
CN119948053A (zh) * 2022-06-30 2025-05-06 摩德斯医疗股份有限公司 抗SARS-CoV-2抗原结合多肽、多肽复合物及其使用方法
US12195546B2 (en) 2022-12-19 2025-01-14 Sanofi CD28/OX40 bispecific antibodies
WO2025076131A1 (en) * 2023-10-03 2025-04-10 Revopsis Therapeutics, Inc. Compostions of multispecific antigen binding polypeptides and methods of use
US20250326823A1 (en) * 2024-04-03 2025-10-23 Modex Therapeutics, Inc. Antigen Binding Polypeptides, Polypeptide Complexes and Methods of Use Thereof
CN119775368B (zh) * 2024-12-06 2025-11-07 扬州大学 基于gE蛋白保守的B细胞表位肽及其在猪伪狂犬病病毒抗体诊断中的应用
CN120399043B (zh) * 2025-04-17 2026-01-27 唯泰科生物科技(武汉)有限公司 抗猪伪狂犬病毒糖蛋白gB的抗体及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006232287B2 (en) * 2005-03-31 2011-10-06 Chugai Seiyaku Kabushiki Kaisha Methods for producing polypeptides by regulating polypeptide association
EP2158221B1 (en) * 2007-06-21 2018-08-29 MacroGenics, Inc. Covalent diabodies and uses thereof
US9216189B2 (en) * 2010-01-25 2015-12-22 Icahn School Of Medicine At Mount Sinai Antibodies which bind type I cannabinoid receptor/angiotensis II receptor heteromers
TWI743461B (zh) * 2011-03-28 2021-10-21 法商賽諾菲公司 具有交叉結合區定向之雙重可變區類抗體結合蛋白
US9458244B2 (en) * 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods
US20140322236A1 (en) * 2013-03-15 2014-10-30 Sdix, Llc Anti-human adora2a antibodies
EP3092250A4 (en) * 2014-01-08 2017-05-24 Moderna Therapeutics, Inc. Polynucleotides for the in vivo production of antibodies
MX2017003847A (es) * 2014-09-25 2017-12-15 Amgen Inc Proteinas biespecificas activables por proteasas.
CN105384825B (zh) * 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
EP3156417A1 (en) * 2015-10-13 2017-04-19 Affimed GmbH Multivalent fv antibodies
RS62437B1 (sr) * 2015-10-25 2021-11-30 Sanofi Sa Trispecifični i/ili trivalentni vezujući proteini za prevenciju ili lečenje hiv infekcije
CA3020633A1 (en) * 2016-04-13 2017-10-19 Sanofi Trispecific and/or trivalent binding proteins
WO2018075564A1 (en) * 2016-10-17 2018-04-26 University Of Maryland, College Park Multispecific antibodies targeting human immunodeficiency virus and methods of using the same
AU2018414456B2 (en) * 2018-03-22 2025-09-11 Universität Stuttgart Multivalent binding molecules
EP3802798A4 (en) * 2018-05-31 2022-05-11 Washington University CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T) FOR TREATMENT OF CANCER
JP7599205B2 (ja) * 2018-06-01 2024-12-13 アンヘレス セラピューティクス インコーポレイテッド 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化
US12365722B2 (en) * 2018-10-19 2025-07-22 University Of Maryland, College Park Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope
AU2019372673A1 (en) * 2018-11-01 2021-05-27 Gracell Biotechnologies (Shanghai) Co., Ltd. Compositions and methods for T cell engineering
TW202104274A (zh) * 2019-04-09 2021-02-01 法商賽諾菲公司 用於治療ｈｉｖ感染之三特異性及／或三價結合蛋白
CN115066274A (zh) * 2019-09-25 2022-09-16 斯图加特大学 三价结合分子

Similar Documents

Publication Publication Date Title
JP2024537826A5 (enExample)
JP2024537804A5 (enExample)
JP2024537828A5 (enExample)
US12540185B2 (en) Fabs-in-tandem immunoglobulin and uses thereof
CA3232364A1 (en) Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof
JP6490038B2 (ja) 交差結合領域の配向性を有する二重可変領域抗体様結合タンパク質
US10266608B2 (en) Fabs-in-tandem immunoglobulin and uses thereof
US20180194861A1 (en) IgM- or IgE-Modified Binding Proteins and Uses Thereof
JP2019522459A5 (enExample)
JP2025503480A5 (enExample)
CN118251411A (zh) 抗原结合多肽、抗原结合多肽复合物及其使用方法
JP2025500918A5 (enExample)
CA3011746C (en) Fabs-in-tandem immunoglobulin and uses thereof